This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On the other hand, the Loo-Riegelman method estimates ka by comparing plasma concentration-time profiles following different administration routes. It provides more comprehensive data, even for drugs with multicompartment characteristics, and aids in understanding drugs' relative bioavailability and absorption characteristics. Yet, it also has limitations, such as the concentration versus time data requirement for both oral and IV drug administration of the same subject and intra-subject between oral and IV administration studies.
The Wagner-Nelson method estimates the absorption rate constant, ka, for drugs administered without assuming zero- or first-order absorption.
Its mathematical formula is derived from the mass balance equation.
A semilog plot of the percent drug unabsorbed and time can help derive ka from the slope of the line.
However, the Wagner-Nelson method is complex and applicable only to drugs with one-compartment kinetics.
Additionally, one must know the elimination rate constant from data collected post-intravenous administration.
Alternatively, the Loo-Riegelman method estimates ka by comparing plasma concentration-time profiles post-administration.
It uses deconvolution methods to understand relative bioavailability and absorption characteristics.
So, it provides more comprehensive data, unlike the Wagner-Nelson method, even with drugs exhibiting multicompartment characteristics.
However, similar to the Wagner-Nelson method, the Loo-Riegelman method shows limitations of intrasubject variability between administration routes. It also assumes that the drug distribution and elimination kinetics remain the same between doses.
繁體中文
